The Asia Pacific Insomnia Market would witness market growth of 4.9% CAGR during the forecast period (2022-2028).
The introduction of technologically advanced medical devices, the rise in the geriatric population, the availability of patented molecules on the market, potential drugs in the clinical pipeline, and potential drugs all have an impact on the growth of the insomnia therapeutics market. Also, nowadays people are becoming more aware of the ill effects of sleep deprivation and thus are well aware of insomnia and its effect.
An irregular bedtime schedule, stimulating activities right before bed, an uncomfortable sleeping environment, as well as using the bed for work, eating, or watching TV are all examples of poor sleep habits. The sleep cycle can be disrupted by using smartphones, TVs, computers, video games, or other screens right before bed which may lead to insomnia. A small snack before bed is acceptable, but if someone eats too much, they might feel physically uncomfortable when lying down. Heartburn, or the backflow of acid & food into the esophagus after eating, is another common condition that can keep people awake.
After the COVID-19 pandemic, "regular" people were exposed to "exceptional events," which led to mental health issues. There are numerous presentations, including emotional issues such as anxiety & sadness, physiologic effects like sleep disruptions and hunger, severe mental illness, and substance abuse. A small percentage of people with these symptoms may encounter serious mental health issues that necessitate additional mental health care, but the majority only experience mild, transient symptoms.
This group may include young children, pregnant women, the elderly, people who already have a mental illness, people who live alone. Another critical element is how the pandemic has affected first aid workers psychologically. The pandemic & widespread social and economic destruction have had a mental toll on society that is unprecedented in modern times, and this is what is fueling the expansion of the insomnia market in this region.
The China market dominated the Asia Pacific Insomnia Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $428.3 million by 2028. The Japan market is anticipated to grow at a CAGR of 4.3% during (2022 - 2028). Additionally, The India market would experience a CAGR of 5.5% during (2022 - 2028).
Based on Distribution Channel, the market is segmented into Hospital, Retail, and Others. Based on Therapy Type, the market is segmented into Pharmacological and Non-Pharmacological.Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Insomnia Market is Projected to reach USD 5.7 Billion by 2028, at a CAGR of 3.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Eisai Co., Ltd., Merck Group, Pfizer, Inc., Vanda Pharmaceuticals, Inc., Cadila Healthcare Ltd. (Zydus Cadila), Sanofi S.A., Viatris, Inc., Takeda Pharmaceutical Company Limited, and Purdue Pharma L.P.
Scope of the Study
Market Segments Covered in the Report:
By Distribution Channel
By Therapy Type
- Pharmacological
- Non-Pharmacological
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
- Eisai Co., Ltd.
- Merck Group
- Pfizer, Inc.
- Vanda Pharmaceuticals, Inc.
- Cadila Healthcare Ltd. (Zydus Cadila)
- Sanofi S.A.
- Viatris, Inc.
- Takeda Pharmaceutical Company Limited
- Purdue Pharma L.P.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Insomnia Market, by Distribution Channel
1.4.2 Asia Pacific Insomnia Market, by Therapy Type
1.4.3 Asia Pacific Insomnia Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Insomnia Market
Chapter 4. Asia Pacific Insomnia Market by Distribution Channel
4.1 Asia Pacific Hospital Market by Country
4.2 Asia Pacific Retail Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Insomnia Market by Therapy Type
5.1 Asia Pacific Pharmacological Market by Country
5.2 Asia Pacific Non-Pharmacological Market by Country
Chapter 6. Asia Pacific Insomnia Market by Country
6.1 China Insomnia Market
6.1.1 China Insomnia Market by Distribution Channel
6.1.2 China Insomnia Market by Therapy Type
6.2 Japan Insomnia Market
6.2.1 Japan Insomnia Market by Distribution Channel
6.2.2 Japan Insomnia Market by Therapy Type
6.3 India Insomnia Market
6.3.1 India Insomnia Market by Distribution Channel
6.3.2 India Insomnia Market by Therapy Type
6.4 South Korea Insomnia Market
6.4.1 South Korea Insomnia Market by Distribution Channel
6.4.2 South Korea Insomnia Market by Therapy Type
6.5 Singapore Insomnia Market
6.5.1 Singapore Insomnia Market by Distribution Channel
6.5.2 Singapore Insomnia Market by Therapy Type
6.6 Malaysia Insomnia Market
6.6.1 Malaysia Insomnia Market by Distribution Channel
6.6.2 Malaysia Insomnia Market by Therapy Type
6.7 Rest of Asia Pacific Insomnia Market
6.7.1 Rest of Asia Pacific Insomnia Market by Distribution Channel
6.7.2 Rest of Asia Pacific Insomnia Market by Therapy Type
Chapter 7. Company Profiles
7.1 Eisai Co., Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Approvals and Trails:
7.2 Takeda Pharmaceutical Company Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trails:
7.3 Vanda Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Research & Development Expenses
7.3.4 Recent strategies and developments:
7.3.4.1 Approval and Trails:
7.4 Cadila Healthcare Ltd. (Zydus Cadila)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Product Launches and Product Expansions:
7.5 Sanofi S.A.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Geographical Expansions:
7.6 Merck Group
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expense
7.8 Viatris, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Acquisition and Mergers:
7.9.2.2 Geographical Expansions:
7.10. Purdue Pharma L.P.
7.10.1 Company Overview
TABLE 1 Asia Pacific Insomnia Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Insomnia Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Retail Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Retail Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Pharmacological Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Pharmacological Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Non-Pharmacological Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Non-Pharmacological Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Insomnia Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Insomnia Market by Country, 2022 - 2028, USD Million
TABLE 19 China Insomnia Market, 2018 - 2021, USD Million
TABLE 20 China Insomnia Market, 2022 - 2028, USD Million
TABLE 21 China Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 22 China Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 23 China Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 24 China Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 25 Japan Insomnia Market, 2018 - 2021, USD Million
TABLE 26 Japan Insomnia Market, 2022 - 2028, USD Million
TABLE 27 Japan Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 28 Japan Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 29 Japan Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 30 Japan Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 31 India Insomnia Market, 2018 - 2021, USD Million
TABLE 32 India Insomnia Market, 2022 - 2028, USD Million
TABLE 33 India Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 34 India Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 35 India Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 36 India Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 37 South Korea Insomnia Market, 2018 - 2021, USD Million
TABLE 38 South Korea Insomnia Market, 2022 - 2028, USD Million
TABLE 39 South Korea Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 40 South Korea Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 41 South Korea Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 42 South Korea Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 43 Singapore Insomnia Market, 2018 - 2021, USD Million
TABLE 44 Singapore Insomnia Market, 2022 - 2028, USD Million
TABLE 45 Singapore Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 46 Singapore Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 47 Singapore Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 48 Singapore Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 49 Malaysia Insomnia Market, 2018 - 2021, USD Million
TABLE 50 Malaysia Insomnia Market, 2022 - 2028, USD Million
TABLE 51 Malaysia Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 52 Malaysia Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 53 Malaysia Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 54 Malaysia Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 55 Rest of Asia Pacific Insomnia Market, 2018 - 2021, USD Million
TABLE 56 Rest of Asia Pacific Insomnia Market, 2022 - 2028, USD Million
TABLE 57 Rest of Asia Pacific Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 58 Rest of Asia Pacific Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 59 Rest of Asia Pacific Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 60 Rest of Asia Pacific Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 61 Key Information – Eisai Co., Ltd.
TABLE 62 Key Information – Takeda Pharmaceutical Company Limited
TABLE 63 Key Information – Vanda Pharmaceuticals, Inc.
TABLE 64 Key Information – Cadila Healthcare Ltd.
TABLE 65 Key Information – Sanofi S.A.
TABLE 66 key Information – Merck GrouP
TABLE 67 Key Information – Pfizer, Inc.
TABLE 68 key information – Viatris, Inc.
TABLE 69 Key Information – Currax Pharmaceuticals LLC
TABLE 70 Key Information – Purdue Pharma L.P.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Eisai Co., Ltd.
FIG 3 Recent strategies and developments: Currax Pharmaceuticals LLC